sar425899 glucagon glp-1 dual agonist sanofi Are peptide conjugates the golden therapy against obesity? Gut hormone-based pharmacology: novel formulations
Description
Starting in mid-2026, Medicare will begin covering these drugs for select patient groups and state Medicaid programs have the option to adopt similar coverage at these discounted rates
Its a peptide
Currently, only 11 states cover GLP-1s for weight loss under their state employee health plan, nine states provide coverage under their state Medicaid program, and five states provide coverage under both programs
Microdosing GLP-1 for Hashimoto's: explore the evidence, potential benefits, safety concerns, and NHS guidance on using GLP-1 receptor agonists for autoimmune thyroid disease and metabolic symptoms.
